Merck & Co. Inc.-1.24% $255.49B ...

Inovio Pharmaceuticals Inc. closed $10.99 below its 52-week high ($14.75), which the company reached on April 1st.

(Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Analyst Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

TORONTO, November 29, 2024--Inovalis Real Estate Investment Trust (the "REIT") (TSX: INO.UN) today announced the signing of an exchange contract for the sale of the Sablière property to a third ...

Short interest in Inovio Pharmaceuticals Inc (NASDAQ:INO) increased during the last reporting ... on the decline of Inovio Pharmaceuticals's stock. Short interest data is updated every two weeks.

You can also see if INO appears on our undervalued or overvalued stock lists. These tools provide a clearer picture of investment opportunities, enabling more informed decisions about where to ...

INOVIO (NASDAQ: INO) has announced a stock option grant to a newly hired employee under its 2022 Inducement Plan. The award ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever INO stock opened at $4.08 on Friday. Inovio Pharmaceuticals has a 1-year low ...